Issue 1
-
Welcome to the Annual Meeting from AACR CEO Margaret Foti, PhD, MD (hc)
Annual Meeting 2021: Discovery Science Driving Clinical Breakthroughs builds on the success of past meetings and promises to deliver breakthrough scientific education and content.
-
Speakers at new plenary to focus on the role of chromosomal instability in cancer
The session honors Angelika Amon, PhD, with presenters (clockwise, top left): Samuel F. Bakhoum, MD, PhD, Karlene A. Cimprich, PhD, Stephen P. Jackson, PhD, and David Pellman, MD.
-
Highlights from the Program Chair: Saturday, April 10
Program Committee Chair Charles Swanton, MBPhD, FAACR, shares some of his selections from the day’s sessions to help plan your Annual Meeting experience.
-
Clinical Trials Plenary sessions showcase how cancer research influences clinical practice
Clinical Trials Committee Co-Chair Julie Brahmer, MD, MSc, said that highlighting so many practice-changing studies demonstrates how translational the Annual Meeting and cancer research has become.
-
Geneticist Frederick W. Alt, PhD, to receive AACR Award for Lifetime Achievement in Cancer Research
Alt’s landmark discovery of dihydrofolate reductase gene amplification provided the first molecular demonstration of genomic instability in mammalian cancer cells.
-
Opening Ceremony will honor newly elected 2021 class of Fellows of the AACR Academy
This year’s class of 25 individuals join the existing 231 distinguished scientists, clinicians, and physician-scientists who have been honored with the AACR’s highest level of recognition.
-
AACR to honor Giusti, Pelosi, Sawyers with Distinguished Public Service Awards
The 2021 recipients exemplify the AACR’s mission to prevent and cure all cancers through research, education, communication, collaboration, science policy, advocacy, and funding.